FDA Grants Supplement Approval for Levothyroxine Sodium by Macleods
The FDA has granted an Abbreviated New Drug Application (ANDA) supplement approval for Levothyroxine Sodium submitted by Macleods Pharmaceuticals.
Company
Pharmaceutical intelligence for Macleods Pharmaceuticals with 24 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.